Development of an adherent cell based virus production process in Mobius® sIngleuse bioreactor by Cunningham, Michael
Engineering Conferences International
ECI Digital Archives
Cell Culture Engineering XV Proceedings
Spring 5-12-2016
Development of an adherent cell based virus
production process in Mobius® sIngleuse bioreactor
Michael Cunningham
EMD MIllipore
Follow this and additional works at: http://dc.engconfintl.org/cellculture_xv
Part of the Biomedical Engineering and Bioengineering Commons
This Abstract is brought to you for free and open access by the Proceedings at ECI Digital Archives. It has been accepted for inclusion in Cell Culture
Engineering XV by an authorized administrator of ECI Digital Archives. For more information, please contact franco@bepress.com.
Recommended Citation
Michael Cunningham, "Development of an adherent cell based virus production process in Mobius® sIngleuse bioreactor" in "Cell
Culture Engineering XV", Robert Kiss, Genentech Sarah Harcum, Clemson University Jeff Chalmers, Ohio State University Eds, ECI
Symposium Series, (2016). http://dc.engconfintl.org/cellculture_xv/204
Abstract: 
Cell culture production processes are being developed as an alternative to the egg-based influenza 
vaccine production.  The egg based method is slow and is subject to avian influenza outbreaks which can 
leave the human population at risk.  The cell culture derived method has several advantages over the 
egg-based production.  It is a robust method which can produce a large volume of vaccine in a short 
period of time thereby reducing the risk of vaccine supply shortages.  This presentation focuses on the 
development of an upstream MDCK cell based influenza A/WS/33 flu production process using Cytodex3 
microcarriers in a 3L Mobius® Single-Use stir tank bioreactor.  Initial development of the cell based 
process was performed in 250mL Corning baffled shake flasks to evaluate microcarrier concentration, 
inoculation and cell growth.   The developed process was then optimized for cell growth and virus 
production by evaluating process control parameters such as; pH, dissolved oxygen and agitation in the 
3L Mobius® system.  The developed process is capable of achieving peak cell densities of 3e6 cells/mL on 
4 g/L of Cytodex3 microcarriers with ~ 35,000HAU/mL of influenza virus.    
 
